Response to “Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis’”

1. Rand, K.
2. Ramos-Goñi, J.M.
3. Akmaz, B.
4. Solé-Feu, L.
5. Armario-Hita, J.-C.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1007/S13555-024-01107-1 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus